Sleep measurement and clinical impact in osteoarthritis and inflammatory arthritis: a scoping review
Authors' conclusion
Sleep disturbance is a prevalent and clinically significant feature of both OA and IA, yet it remains underrepresented in research and routine care. This review highlights substantial heterogeneity in sleep assessment and consistent discrepancies between subjective and objective measures.
Study context
- Population
- Studies of sleep in osteoarthritis (OA) and/or inflammatory arthritis (IA); Medline, EMBASE, CINAHL, Cochrane Central, PsycINFO, grey literature, ClinicalTrials.gov
- Participants
- 283 records265 studies
- Comparison
- IA vs OA vs Mixed populations
- IAn = 171
- OAn = 77
- Mixed populationsn = 17
- Outcome
- How sleep has been assessed, and prevalence, characteristics and relationships of sleep disturbances in OA and IA
Methodological detailsJBI guidelines, PRISMA-ScR, RU-SATED framework, narrative synthesis
- JBI guidelines
- PRISMA-ScR
- RU-SATED framework
- Narrative synthesis
Main finding
As reported in the abstract
Global sleep disturbances in OA and IA participants
∼40-90%
Original publication
Sleep measurement and clinical impact in osteoarthritis and inflammatory arthritis: a scoping review. Rheumatology (Oxford). Published 11 August 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →